BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12215478)

  • 1. Angiotensin II induces catecholamine release by direct ganglionic excitation.
    Dendorfer A; Thornagel A; Raasch W; Grisk O; Tempel K; Dominiak P
    Hypertension; 2002 Sep; 40(3):348-54. PubMed ID: 12215478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel effect of angiotensin on renal sympathetic nerve activity in mice.
    Ma X; Abboud FM; Chapleau MW
    J Hypertens; 2001 Mar; 19(3 Pt 2):609-18. PubMed ID: 11327637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganglionic action of angiotensin contributes to sympathetic activity in renin-angiotensinogen transgenic mice.
    Ma X; Sigmund CD; Hingtgen SD; Tian X; Davisson RL; Abboud FM; Chapleau MW
    Hypertension; 2004 Feb; 43(2):312-6. PubMed ID: 14699002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous angiotensin II does not facilitate norepinephrine release in the heart.
    Lameris TW; de Zeeuw S; Duncker DJ; Alberts G; Boomsma F; Verdouw PD; van den Meiracker AH
    Hypertension; 2002 Oct; 40(4):491-7. PubMed ID: 12364352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separation of peripheral and central cardiovascular actions of angiotensin II.
    Kooner JS; May CN; Peart S; Mathias CJ
    Am J Physiol; 1997 Dec; 273(6):H2620-6. PubMed ID: 9435595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitation by procaterol, a beta-adrenoceptor agonist, of noradrenaline release in the pithed rat independently of angiotensin II formation.
    Kotsonis P; Majewski H
    Br J Pharmacol; 1994 Nov; 113(3):781-8. PubMed ID: 7858867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin inhibits sympathetic ganglionic transmission but potentiates sympathetic neuroeffector responses in hindlimb vasculature of rabbits.
    Patel KP; Schmid PG
    J Pharmacol Exp Ther; 1988 Jun; 245(3):779-85. PubMed ID: 2898522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of angiotensin II receptors inhibits the increase in blood pressure induced by insulin.
    Nakata T; Takeda K; Hatta T; Kiyama M; Moriguchi J; Miki S; Kawa T; Morimoto S; Nakamura K; Uchida A; Itoh H; Sasaki S; Nakagawa M
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):248-52. PubMed ID: 9475266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurohumoral contributions to chronic angiotensin-induced hypertension.
    Bruner CA; Fink GD
    Am J Physiol; 1986 Jan; 250(1 Pt 2):H52-61. PubMed ID: 2867686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No involvement of the AT2-receptor in angiotensin II-enhanced sympathetic transmission in vitro.
    Nap A; Balt JC; Pfaffendorf M; Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):100-5. PubMed ID: 12806592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased sympathetic activity in rats submitted to chronic intermittent hypoxia.
    Zoccal DB; Bonagamba LG; Oliveira FR; Antunes-Rodrigues J; Machado BH
    Exp Physiol; 2007 Jan; 92(1):79-85. PubMed ID: 17085676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the AT(2)-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission.
    Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):181-7. PubMed ID: 12563569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.
    Ohlstein EH; Brooks DP; Feuerstein GZ; Ruffolo RR
    Pharmacology; 1997 Nov; 55(5):244-51. PubMed ID: 9399334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral presynaptic facilitatory effect of angiotensin II on noradrenaline release in anesthetized rabbits.
    Szabo B; Hedler L; Schurr C; Starke K
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):968-75. PubMed ID: 1694920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural and humoral mechanisms of angiotensin-dependent hypertension.
    Cox BF; Bishop VS
    Am J Physiol; 1991 Oct; 261(4 Pt 2):H1284-91. PubMed ID: 1681742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin selectively activates a subpopulation of postganglionic sympathetic neurons in mice.
    Ma X; Chapleau MW; Whiteis CA; Abboud FM; Bielefeldt K
    Circ Res; 2001 Apr; 88(8):787-93. PubMed ID: 11325870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term diabetic hyperglycemia suppresses celiac ganglia neurotransmission, thereby impairing sympathetically mediated glucagon responses.
    Mundinger TO; Cooper E; Coleman MP; Taborsky GJ
    Am J Physiol Endocrinol Metab; 2015 Aug; 309(3):E246-55. PubMed ID: 26037249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II-based hypertension and the sympathetic nervous system: the role of dose and increased dietary salt in rabbits.
    McBryde FD; Guild SJ; Barrett CJ; Osborn JW; Malpas SC
    Exp Physiol; 2007 Sep; 92(5):831-40. PubMed ID: 17468201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II exerts differential actions on renal nerve activity and heart rate.
    Kumagai K; Reid IA
    Hypertension; 1994 Oct; 24(4):451-6. PubMed ID: 8088910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravenous angiotensin II infusion on responses to hypothalamic PVN injection of bicuculline.
    LaGrange LP; Toney GM; Bishop VS
    Hypertension; 2003 Dec; 42(6):1124-9. PubMed ID: 14597646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.